普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究

王蔓莉; 陈辉; 段智; 许奇美; 李贞

doi:10.19401/j.cnki.1007-3639.2024.07.002

您当前的位置：

首页 >

文章列表页 >

普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究

论著 | 更新时间：2025-12-31

- 普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究
- A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis
- 中国癌症杂志 2024年34卷第7期页码：628-638
- 作者机构：
  
  长沙市第一医院（中南大学湘雅医学院附属长沙医院）病理科，湖南长沙 410005
- 作者简介：
  
  [ "王蔓莉（ORCID: 0009-0009-7269-8181），硕士，主治医师。" ]
  陈辉（ORCID: 0009-0000-0626-8639），本科，主任医师，长沙市第一医院（中南大学湘雅医学院附属长沙医院）病理科主任。
- 基金信息：
  
  湖南省卫生健康委科研项目(AGFJ2021347)
- DOI：10.19401/j.cnki.1007-3639.2024.07.002
  中图分类号： R734.2
- 收稿：2023-11-17，
  
  修回：2024-02-27，
  
  纸质出版：2024-07-30
- 稿件说明：
移动端阅览
王蔓莉, 陈辉, 段智, 等. 普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究[J]. 中国癌症杂志, 2024,34(7):628-638.

Manli WANG, Hui CHEN, Zhi DUAN, et al. A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis[J]. China Oncology, 2024, 34(7): 628-638.
王蔓莉, 陈辉, 段智, 等. 普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究[J]. 中国癌症杂志, 2024,34(7):628-638. DOI： 10.19401/j.cnki.1007-3639.2024.07.002.

Manli WANG, Hui CHEN, Zhi DUAN, et al. A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis[J]. China Oncology, 2024, 34(7): 628-638. DOI： 10.19401/j.cnki.1007-3639.2024.07.002.

摘要

背景与目的：

阐明介导肿瘤相关成纤维细胞（cancer-associated fibroblasts，CAFs）与肿瘤细胞之间通讯的信号分子仍然是一个巨大的挑战，这些信号分子对癌症转移至关重要。本研究旨在探讨普列克底物蛋白2（pleckstrin-2，PLEK2）/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制。

方法：

选择人肺腺癌细胞系H1299和人胚胎肺细胞MRC

-5作为研究对象。用表达PLEK2的慢病毒（PLEK2）和载体对照（Vector）转染H1299细胞，并在转染24 h后分离外泌体（Vector_exo、PLEK2_exo）。采用miR-196a模拟物或抑制剂转染MRC-5细胞。通过蛋白质印迹法（Western blot）分析PLEK2和上皮-间充质转化（epithelial-mesenchymal transition，EMT）相关蛋白水平，采用聚合酶链反应（polymerase chain reaction，PCR）分析miR-196a表达，采用transwell实验测定细胞转移和侵袭能力。将6只雌性BALB/c-nu小鼠随机分为Vector组和PLEK2组，每组3只。通过尾静脉向各组小鼠注射转染Vector或PLEK2的H1299细胞。4周后，取出肺组织进行H-E染色和免疫组织化学染色分析α-平滑肌肌动蛋白（α-smooth muscle actin，α-SMA）表达。所有动物实验均经长沙市第一医院（中南大学湘雅医学院附属长沙医院）伦理委员会批准（伦理编号为EI-2021-103）。

结果：

与Vector组相比，PLEK2组小鼠肺结节数和转移灶中α-SMA表达显著增加（

0.001）。与Vector组相比，PLEK2组H1229细胞中miR-196a表达水平显著增加（

0.05），并且PLEK2_exo中miR-196a表达水平显著高于Vector_exo（

0.05）。与Vector_exo组相比，PLEK2_exo组MRC-5细胞中miR-196a、α-SMA和成纤维细胞活化蛋白（fibroblast activation protein，FAP）表达水平显著增加（

0.05）。与阴性对照（negative control，NC）相比，miR-196a转染的MRC-5细胞中α-SMA和FAP表达水平显著增加（

0.05）。相反，通过miR-196a抑制剂（si-miR-196a#1、si-miR-196a#）转染，α-SMA和FAP表达水平被显著抑制（

0.05）。与NC-CM组相比，miR-196a-CM组H1299细胞的转移、侵袭细胞数和波形蛋白（vimentin）表达均显著增加（

0.001），E-钙黏蛋白（E-cadherin）表达显著降低（

0.001）。此外，与Vector_exo-CM组相比，PLEK2_exo-CM组H1299细胞的转移、侵袭细胞数和vimentin表达均显著增加（

0.01），E-cadherin表达显著降低（

0.001）。

结论：

PLEK2上调能够增强肺癌细胞来源的外泌体miR-196a水平，从而促进CAFs激活。激活的CAFs能够进一步增强肺癌细胞的侵袭能力。

Abstract

Background and purpose:

It is still a great challenge to clarify the signal molecules that mediate the communication between cancer-associated fibroblasts (CAFs) and tumor cells. These signal molecules are very important for cancer metastasis. The purpose of this study was to explore the communication mechanism of pleckstrin-2/miR-196a signal axis mediated by lung cancer cells in tumor microenvironment.

Methods:

Human lung adenocarcinoma cell line H1299 and human embryonic lung cell MRC-5 were selected as the research objects. H1299 cells wer

e transfected with lentivirus (PLEK2) expressing PLEK2 and Vector control

and exosomes (Vector_exo

PLEK2_exo) were isolated after 24 h of transfection. MRC-5 cells were transfected with miR-196a mimetic or inhibitor. The expressions of PLEK2 and epithelial-mesenchymal transition (EMT)-related proteins were analyzed by Western blot. The expression of miR-196a was analyzed by polymerase chain reaction (PCR)

and the metastasis and invasion ability of cells were determined by transwell assay. Six female BALB/c-nu mice were randomly divided into Vector group and PLEK2 group

with 3 mice in each group. Mice in each group were injected with H1299 cells transfected with Vector or PLEK2 through the tail vein. After 4 weeks

lung tissue was taken out for H-E staining and immunohistochemical staining to analyze the expression of α-smooth muscle actin (α-SMA). All animal experiments were approved by the ethics committee of First Hospital of Changsha City (Changsha Hospital

Xiangya School of Medicine

Central South University) (ethics number: EI-2021-103).

Results:

Compared with the Vector group

the number of pulmonary metastatic nodules and the expression of α-SMA in metastatic cancer in PLEK2 group increased significantly (

0.001). Compared with Vector group

the expression level of miR-196a in H1229 cells in PLEK2 group increased significantly (

0.05)

and the expression level of miR-196a was significantly higher in PLEK2_exo than in Vector_exo (

0.05). Compared with Vector_exo group

the expression levels of miR-196a

α-SMA and fibroblast activation protein (FAP) in MRC-5 cells in PLEK2_exo group increased significantly (

0.05). Compared with the negative control (NC)

the expression levels of α-SMA and FAP in MRC-5 cells transfected with miR-196a increased significantly (

0.05). On the contrary

by transfection with miR-196a inhibitors (si-miR-196a#1 and si-miR-196a#)

the expression levels of α-SMA

and FAP were significantly inhibited (

0.05). Compared with NC-CM group

the number of metastatic cells

invasive cells and the expression of vimentin in miR-196a-CM group increased significantly (

0.001)

and the expression of E-cadherin decreased significantly (

0.001). In addition

compared with Vector_exo-CM group

PLEK2_exo-CM group had significant increase in number of metastatic and invasive cells and the expression of vimentin (

0.01)

and significant decrease in the expression of E-cadherin (

0.001).

Conclusion:

Upregulation of PLEK2 can enhance the level of exosomes miR-196a derived from lung cancer cells

thereby promoting the activation of CAFs. The activated CAFs can further enhance the invasive ability of lung cancer cells.

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R L , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .

MILLER K D , NOGUEIRA L , DEVASIA T , et al. Cancer treatment and survivorship statistics, 2022 [J ] . CA Cancer J Clin , 2022 , 72 ( 5 ): 409 - 436 .

CHAFT J E , RIMNER A , WEDER W , et al. Evolution of systemic therapy for stagesⅠ-Ⅲ non-metastatic non-small-cell lung cancer [J ] . Nat Rev Clin Oncol , 2021 , 18 ( 9 ): 547 - 557 .

ENTEZARI M , GHANBARIRAD M , TAHERIAZAM A , et al. Long non-coding RNAs and exosomal lncRNAs: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling [J ] . Biomedecine Pharmacother , 2022 , 150 : 112963 .

WANG G C , ZHOU Q , XU Y , et al. Emerging roles of pleckstrin-2 beyond cell spreading [J ] . Front Cell Dev Biol , 2021 , 9 : 768238 .

WEN Y S , GUO G R , YANG L J , et al. A tumor microenvironment gene set-based prognostic signature for non-small-cell lung cancer [J ] . Front Mol Biosci , 2022 , 9 : 849108 .

HU S C , MA J H , SU C , et al. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis [J ] . Acta Biomater , 2021 , 135 : 567 - 581 . DOI: 10.1016/j.actbio.2021.09.003 http://doi.org/10.1016/j.actbio.2021.09.003

PATHANIA A S , PRATHIPATI P , CHALLAGUNDLA K B . New insights into exosome mediated tumor-immune escape: clinical perspectives and therapeutic strategies [J ] . Biochim Biophys Acta Rev Cancer , 2021 , 1876 ( 2 ): 188624 .

NIU L R , YANG W L , DUAN L L , et al. Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer [J ] . Mol Ther Nucleic Acids , 2021 , 23 : 42 - 54 .

TAN Z F , XUE H B , SUN Y L , et al. The role of tumor inflammatory microenvironment in lung cancer [J ] . Front Pharmacol , 2021 , 12 : 688625 .

XU K H , ZHANG C P , DU T T , et al. Progress of exosomes in the diagnosis and treatment of lung cancer [J ] . Biomedecine Pharmacother , 2021 , 134 : 111111 .

ZHAO X Y , SHU D L , SUN W J , et al. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop [J ] . Cancer Commun , 2022 , 42 ( 10 ): 987 - 1007 .

LIU J H , CHEN H , QIAO G B , et al. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma [J ] . Cancer Immunol Immunother , 2023 , 72 ( 4 ): 881 - 893 .

SHAO W , AZAM Z , GUO J T , et al. Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2 [J ] . Lab Invest , 2022 , 102 ( 12 ): 1314 - 1322 . DOI: 10.1038/s41374-022-00821-8 http://doi.org/10.1038/s41374-022-00821-8

WU D M , DENG S H , ZHOU J , et al. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer [J ] . Int J Cancer , 2020 , 146 ( 9 ): 2563 - 2575 .

XIA Q L , HE X M , MA Y , et al. 5-mRNA-based prognostic signature of survival in lung adenocarcinoma [J ] . World J Clin Oncol , 2023 , 14 ( 1 ): 27 - 39 .

WANG F , ZHANG C Q , CHENG H , et al. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2 [J ] . Cell Death Dis , 2021 , 12 ( 10 ): 901 . DOI: 10.1038/s41419-021-04155-z http://doi.org/10.1038/s41419-021-04155-z

WU C X , GU J M , GU H B , et al. The recent advances of cancer associated fibroblasts in cancer progression and therapy [J ] . Front Oncol , 2022 , 12 : 1008843 .

SHELTON M , ANENE C A , NSENGIMANA J , et al. The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma [J ] . Biochim Biophys Acta Rev Cancer , 2021 , 1875 ( 1 ): 188456 .

MA Y N , WANG S S , LIEBE R , et al. Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma [J ] . Chin Med J , 2021 , 134 ( 21 ): 2544 - 2546 .

CUI J Z , YUAN Y , SHANMUGAM M K , et al. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways [J ] . Int J Biol Sci , 2021 , 17 ( 15 ): 4254 - 4270 . DOI: 10.7150/ijbs.60805 http://doi.org/10.7150/ijbs.60805

QIU H , XIE Z Q , TANG W F , et al. Association between microRNA-146a, -499a and-196a-2 SNPs and non-small cell lung cancer: a case-control study involving 2249 subjects [J ] . Biosci Rep , 2021 , 41 ( 2 ): BSR20201158 .

QIN X , GUO H Y , WANG X N , et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5 [J ] . Genome Biol , 2019 , 20 ( 1 ): 12 . DOI: 10.1186/s13059-018-1604-0 http://doi.org/10.1186/s13059-018-1604-0

LIU E C , LEE T T , WU S L , et al. Abstract 1035: PLEK2 promotes epithelial mesenchymal transition through increasing Snail1 in lung cancer cells [J ] . Cancer Res , 2019 , 79 ( 13_Supplement ): 1035 .

HAN X , MEI Y , MISHRA R K , et al. Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models [J ] . J Clin Invest , 2023 , 133 ( 6 ): e159638 .

浏览量

2290

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

MYC通过靶向CD47促进前列腺癌增殖和转移的机制研究

没食子酸增强CAR-T细胞抗实体瘤作用的研究

循环肿瘤细胞在胆管癌侵袭转移中的作用机制研究进展及展望

生物3D打印在肿瘤研究及组织工程中的应用

单细胞测序在口腔鳞状细胞癌研究中的价值